Enteral Formula With Fructose
Dietary SupplementLow-carbohydrate Enteral Formula With Fructose
NCT Number: NCT03003507
Hyperglycemia is a known risk factor for mortality in critically ill patients. Most of these patients receive enteral feeding. There is controversy about ideal carbohydrate composition of these diets. The aim of this study was to compare an enteral formula with the same proportion of carbohydrates with and without fructose on blood glucose levels.
Looking for future studies?
Notify Me20 year and older
All sexes
Interventional
Phase 4
Randomized, cross-over, controlled, double-blind clinical trial without washout. Adult patients admitted to the ICU who presented capillary glycemia values> 180mg / dl with a full and exclusive enteral diet. They were randomized and observed for 4 days (2 days with each diet: with / without fructose). Capillary glycemia was measured 4 / 4h.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Low-carbohydrate Enteral Formula With Fructose
Low-carbohydrate Enteral Formula Without Fructose
Time frame: four days
To evaluate the glycemic oscillation during the use of enteral feedings
Hospital Moinhos de Vento
Other
Glycemic Index Variation During Low-carbohydrate Enteral Formula With and Without Fructose in Critically Ill Patients: A Cross-over Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05442853
Critical Illness, Diabetes Mellitus
Gainesville, Florida, United States
View Trial DetailsNCT06056167
Critical Illness, Diabetes Mellitus
Riyadh, Saudi Arabia
View Trial DetailsNCT07687368
Continuous Glucose Monitoring, Critical Care Nursing
Barcelona, Catalonia, Spain
View Trial DetailsNCT07261865
Critical Illness, Diabetes (DM)
Leeuwarden, Provincie Friesland, Netherlands
View Trial Details